---
title: "TAVR outcomes in Queensland: urban, regional and remote 12-month mortality analysis"
id: "medrxiv-23-urban-regional-and-remote-outcomes-following-tavr-for-queensland-patients-a"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-23-urban-regional-and-remote-outcomes-following-tavr-for-queensland-patients-a"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.22.26366273v1?rss=1"
published_at: "2026-10-26T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# TAVR outcomes in Queensland: urban, regional and remote 12-month mortality analysis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-23-urban-regional-and-remote-outcomes-following-tavr-for-queensland-patients-a
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.22.26366273v1?rss=1)
- **Published At:** 2026-10-26T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This multicentre retrospective cohort used the **Australian Cardiac Outcomes Registry** to identify all Queensland residents who underwent **TAVR** from April 2018 to 27 March 2026. - Rurality was classified by postcode using the **Modified Monash Model (MMM)** and grouped as urban (MMM1), regional (MMM2–4), or remote (MMM5–7). - The primary endpoint was **12-month mortality**, analyzed with Kaplan–Meier curves and Cox proportional hazards models. - The cohort included 6,813 patients: 4,246 (62%) urban, 2,092 (31%) regional, and 475 (7%) remote. - Observed 12-month all-cause mortality rates were similar across groups (urban 5.0%; regional 4.9%; remote 4.8%); log-rank P=0.929 and χ2=0.991 reported. - Multivariable modelling confirmed no independent association between rurality category and 12-month mortality. - At procedure, regional and remote patients were younger, had more comorbidity and more severe **aortic stenosis**, yet lower STS scores than urban patients. - Independent predictors of 12-month mortality included clinical frailty score, non-transfemoral access, STS score, atrial fibrillation/flutter, and moderate–severe chronic lung disease. - The authors noted that registry data include only patients who reached and received **TAVR**, and therefore may omit older rural patients who face barriers to diagnosis, referral, or pre-procedural workup. - Funding: no external funding or sponsor involvement; competing interests: none declared.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.medrxiv.org/content/10.64898/2026.10.22.26366273v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Urban, regional and remote outcomes following TAVR for Queensland patients: a retrospective cohort study [ View ORCID Profile](http://orcid.org/0009-0000-3767-9035)Patrick Cameron, Anthony Brazzale, Greg Starmer, Joseph V. Moxon doi: https://doi.org/10.64898/2026.10.22.26366273 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Patrick Cameron 1 James Cook University College of Medicine & Dentistry Cairns Campus; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Patrick%2BCameron%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Cameron%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APatrick%2BCameron%2B) * [ORCID record for Patrick Cameron](http://orcid.org/0009-0000-3767-9035 "Open in new tab") * For correspondence: patrick.cameron@my.jcu.edu.au Anthony Brazzale 2 Northern Heart Specialists; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anthony%2BBrazzale%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Brazzale%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAnthony%2BBrazzale%2B) Greg Starmer 2 Northern Heart Specialists; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Greg%2BStarmer%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Starmer%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGreg%2BStarmer%2B) Joseph V. Moxon 3 James Cook University * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Joseph%2BV.%2BMoxon%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Moxon%20JV&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJoseph%2BV.%2BMoxon%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.10.22.26366273v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1330912/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.10.22.26366273v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1330912/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.10.22.26366273v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1330912/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.10.22.26366273v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1330912/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.10.22.26366273v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1330912/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background Transcatheter aortic valve replacement (TAVR) offers a minimally invasive approach to treat severe aortic stenosis (AS) but can only be performed at centres meeting strict regulatory requirements. It remains unclear whether this requirement restricts TAVR access for patients residing in rural Australia, and whether such people experience poorer outcomes than metropolitan counterparts as a result. Methods This multicentre retrospective cohort study used Australian Cardiac Outcomes Registry data. All Queensland residents who underwent TAVR between April 2018 and 27 March 2026 were included. Rurality was assigned by postcode using the Modified Monash Model (MMM) and grouped as urban (MMM1), regional (MMM2-4), or remote (MMM5-7). The primary outcome was 12-month mortality and was investigated using Kaplan-Meier and Cox proportional hazards analyses. Findings Among 6813 patients, 4246 (62%) were urban, 2092 (31%) regional, and 475 (7%) remote. Twelve-month all-cause mortality did not differ by rurality (urban: 211 [5.0%]; regional: 103 [4.9%]; remote: 23 [4.8%]; χ2=0.991, log-rank P=0.929), a finding confirmed in multivariable analysis. At the time of TAVR, regional and remote patients were younger, more comorbid, had more severe AS, and lower STS scores than urban counterparts. Clinical frailty score, non-transfemoral access, STS score, atrial fibrillation or flutter, and moderate-severe chronic lung disease independently predicted 12-month mortality. Interpretation TAVR outcomes were comparable between rurality groups, suggesting equitable care within Queensland's centralised TAVR model. However, registry data only captures patients who underwent TAVR and may miss older rural patients facing barriers to AS diagnosis, referral, or procedural workup. Funding There was no funding or sponsor involvement. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study protocol was approved by the local Human Research Ethics Committee and James Cook University (HREC/2025/QCH/117308), and a waiver of consent to access data was granted. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Individual participant data will not be made available to others. The data were provided by ACOR under a data-use agreement and the conditions of the ethics approval for this study, which do not permit release of participant-level data outside the research team. Readers are welcome to contact the corresponding author with any questions about the study. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.10.22.26366273v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.10.22.26366242v1 "Clinical and prognostic significance of the C-reactive protein-albumin-lymphocyte \(CALLY\) index in breast cancer: a systematic review and meta-analysis")[Next ](https://www.medrxiv.org/content/10.64898/2026.10.22.26366267v1 "Polygenic liability for major depression, schizophrenia and bipolar disorder and treatment outcome across major psychiatric disorders") Posted October 26, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.10.22.26366273v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/10/26/2026.10.22.26366273.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.10.22.26366273v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/10/26/2026.10.22.26366273.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Urban, regional and remote outcomes following TAVR for Queensland patients: a retrospective cohort study Patrick Cameron, Anthony Brazzale, Greg Starmer, Joseph V. Moxon medRxiv 2026.10.22.26366273; doi: https://doi.org/10.64898/2026.10.22.26366273 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.22.26366273v1%26text%3DUrban%252C%2520regional%2520and%2520remote%2520outcomes%2520following%2520TAVR%2520for%2520Queensland%2520patients%253A%2520a%2520retrospective%2520cohort%2520study "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.22.26366273v1%26t%3DUrban%252C%2520regional%2520and%2520remote%2520outcomes%2520following%2520TAVR%2520for%2520Queensland%2520patients%253A%2520a%2520retrospective%2520cohort%2520study "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.22.26366273v1%26title%3DUrban%252C%2520regional%2520and%2520remote%2520outcomes%2520following%2520TAVR%2520for%2520Queensland%2520patients%253A%2520a%2520retrospective%2520cohort%2520study%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.22.26366273v1%26title%3DUrban%252C%2520regional%2520and%2520remote%2520outcomes%2520following%2520TAVR%2520for%2520Queensland%2520patients%253A%2520a%2520retrospective%2520cohort%2520study "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.10.22.26366273) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.10.22.26366273v1&count=horizontal&via=&text=Urban%2C%20regional%20and%20remote%20outcomes%20following%20TAVR%20for%20Queensland%20patients%3A%20a%20retrospective%20cohort%20study&counturl=www.medrxiv.org/content/10.64898/2026.10.22.26366273v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (635) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (914) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (348) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4951) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (491) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (425) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (674) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1675) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16178) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1236) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7220) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (747) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1092) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5232) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1457) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1815) * [Hematology](https://www.medrxiv.org/collection/hematology) (597) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1373) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16438) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1194) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (692) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (740) * [Neurology](https://www.medrxiv.org/collection/neurology) (7513) * [Nursing](https://www.medrxiv.org/collection/nursing) (375) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1114) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1290) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1034) * [Oncology](https://www.medrxiv.org/collection/oncology) (3716) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1081) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (401) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (463) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (496) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (143) * [Pathology](https://www.medrxiv.org/collection/pathology) (718) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1846) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (749) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (781) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6074) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9928) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2502) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1501) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1263) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (657) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (796) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (595) * [Surgery](https://www.medrxiv.org/collection/surgery) (796) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (316) * [Urology](https://www.medrxiv.org/collection/urology) (304) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Video: _There are no videos for this paper._ Powered by [![Hypothes.is logo](https://connect.biorxi
## Related Clinical Research

- [Retinal changes on OCT may predict atrial fibrillation risk years earlier](https://medichelpline.com/clinical-feed/medical-news-today-0-how-changes-in-the-eyes-may-help-spot-afib-risk-years-early.md)
- [New oral anticoagulants linked to slower cognitive decline in Alzheimer’s patients with AFib](https://medichelpline.com/clinical-feed/medical-news-today-0-new-oral-anticoagulants-may-help-slow-cognitive-decline-in-alzheimer-s-disease.md)
- [Understanding Heart Health at Every Life Stage for Women](https://medichelpline.com/clinical-feed/aha-news-1-why-every-stage-of-life-matters-for-a-woman-s-heart-health.md)
- [New Multi-Society Framework Defines Female Life Stages for Heart Health](https://medichelpline.com/clinical-feed/aha-news-2-leading-health-groups-redefine-heart-health-for-girls-and-women.md)
- [Sex Differences in Cognitive Impairment and Dementia After Incident Atrial Fibrillation and the Im](https://medichelpline.com/clinical-feed/medrxiv-7-a-population-based-study-of-sex-differences-in-cognitive-impairment-and.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.